Clincosm LogoSign in Get a demo

Hormone-resistant Prostate Cancer

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Serum Samples in Studying Emotional Stress in Prostate Cancer

Completed
  • Hormone-Resistant Prostate Cancer
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Mar 8, 2022

Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles, Newport Beach, Rochester

Recruiting
  • Breast Cancer
  • +2 more
  • dietary intervention
  • +2 more
  • Los Angeles, California
  • +2 more
Nov 16, 2021

HER2-positive Metastatic Breast Cancer, Ovarian Cancer, Hormone-resistant Prostate Cancer Trial in Lille (Blood sample

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • +3 more
  • Blood sample collection
  • Lille, France
    Centre Oscar Lambret
Oct 5, 2021

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Radiation Therapy
  • Buffalo, New York
  • +1 more
Aug 4, 2021

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles, Ann Arbor,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Los Angeles, California
  • +2 more
Aug 3, 2021

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Aug 3, 2021

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2021

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer

Terminated
  • Hormone-Resistant Prostate Cancer
  • +2 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Los Angeles, California
  • +2 more
Apr 1, 2021

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 2, 2021

Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma Trial in Sacramento (Cabazitaxel, Prednisone)

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • Stage IV Prostate Adenocarcinoma
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 21, 2021

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • ipilimumab
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
  • +1 more
Sep 23, 2020

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Retrospective Data of XOFIGO

Completed
  • Prostate Cancer
  • +2 more
  • clinical database
  • Montpellier, Herault, France
  • +7 more
Aug 14, 2020

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sodium selenite
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 14, 2020

Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma Trial in Portland, Seattle

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Biopsy of Prostate
  • +3 more
  • Portland, Oregon
  • +2 more
Sep 19, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Hormone-refractory Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in United States

Completed
Has Results
  • Hormone-refractory Prostate Cancer
  • +4 more
  • Duarte, California
  • +5 more
Feb 5, 2019

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Washington, District of Columbia
  • +19 more
Aug 13, 2018